Author:
Zhou Changrui,Yan Haijun,Yang Wenge,Hu Yonghong
Funder
National Natural Science Foundation of China
National Key Research and Development Program of China
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference41 articles.
1. Molecular mechanisms mediating the effects of l-α-glyceryl- phosphorylcholine, a new cognition-enhancing drug, on behavioral and biochemical parameters in young and aged rats;Schettini;Pharmacol., Biochem. Behav.,1992
2. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data;Parnetti;Mech Ageing Dev,2001
3. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, doubleblind, randomized, placebocontrolled trial;De Jesus Moreno Moreno;Clin. Ther.,2003
4. P300 latency changes in patients with mild cognitive impairment after taking choline alphoscerate; A preliminary study;Han;eNeurologicalSci,2018
5. Safety assessment of AGPC as a food ingredient;Brownawell;Food Chem. Toxicol.,2011